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68S Abstracts May Supplement 2013Objectives: To determine trends in the incidence of
amputation and mode of revascularization [endovascular
(ENDO) vs open surgical (OPEN) vs both (HYBRID)]
among persons with peripheral arterial disease (PAD) in
a deﬁned population.
Methods: A population based cohort study of resi-
dents of a single county was conducted from 1990 to
2009. Procedures were identiﬁed by ICD9/CPT codes.
Age and gender-adjusted Poisson regression analysis was
used to determine 5-year incidence trends.
Results: A total of 773 residents (mean age 68.6 yrs)
underwent 1906 limb revascularization procedures; 61%
for critical limb ischemia (CLI) and 32% for claudication
with a median of two procedures per limb. The cohort
was predominantly male (58.5%; P < .0001) and Caucasian
(96.5%). Initial ENDO procedures were more frequently
for claudication (54%) and OPEN for CLI (58%). Five-
year incidence rates showed signiﬁcant decreases in
OPEN and increases in ENDO and HYBRID revasculari-
zations over the 20-year period (P < .001; Fig). Total
revascularizations increased from 91 to 118 (P ¼ .0014)
and amputations decreased from 21 to 13/100,000
person-years (P ¼ .0123). Primary amputations decreased
from 13 to 5/100,000 person-years (P ¼ .0002).
Conclusions: In this population based study spanning
20 years, the incidence of amputations and OPEN revascu-
larizations decreased signiﬁcantly among PAD patients,
with concomitant increases in total, ENDO and HYBRID
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Two-year Follow-up In Diabetic Patients With
Occlusive Disease of the SFA Treated With e-PTFE
Endografts Compared to Non-diabetics
Rombout Kruse1, Floris B. Poelmann1, Michel Reijnen3,
Robert Lind1, Frans L. Moll2, Wilbert M. Fritschy1.
1Isala Clinics, Zwolle, The Netherlands; 2UniversityMedical Centre Utrecht, Utrecht, The Netherlands;
3Rijnstate Hospital, Arnhem, The Netherlands
Objectives: Diabetic patients form an important chal-
lenge in treating occlusive disease of the SFA. In this study
we have evaluated the results of 327 patients treated in two
hospitals in the Netherlands over a 10-year period. These
patients were treated with an e-PTFE nitinol self-expand-
ing endograft in the SFA/popliteal region for occlusive
disease. The aim of this study is to compare the results of
patients with diabetes (DM), with patients that didn’t
have diabetes (non-DM).
Methods: Male to female ratio was 73.7 vs 26.3%.
Mean age during surgery was 69.03 years. All patients
included had clinical symptoms of Intermittend Claudica-
tion or critical Limb Ischaemia (CLI). SFA lesions of both
groups of patients were scored according to the Trans
Atlantic Inter Society Consensus (TASC II). Follow up
was done after 3, 6, and 12 months, and every year there-
after. 36.7% of patients had DM (n ¼ 120). Our objective
was to asses primary and secondary 2-year patency in both
DM patients and in non-DM patients and compared the
two. Statistical analysis was done formng Kaplan Meier
survival curves to describe patency during follow-up.
The two groups were compared using Log Rank
(Mantel-Cox) analysis. Follow up included duplex ultra-
sonography and ankle brachial indices as well as pysical
examination.
Results: No statistical differences were found between
the two groups with respect to age and TASC classiﬁcation.
TASC II classiﬁcation in DM group was TASC A/B/C/
D: 25/39/25/31 and in the non-DM group: 51/54/
37/65, P value .436 (N.S.). 2-year primary and secondary
patency was 60,8 and 90% in the DM group (n ¼ 120),
and 65.2, and 82.6% in the non-DM group (n ¼ 207).
Log-rank (mantel Cox) analysis of the two Kaplan Meier
curves showed P values of .442 and .069 (both NS).
Conclusions: 2 year primary and secondary patency
rates of DM patients were equal to that of non-DM
patients. The 2-year secondary patency of 90% in the
DM group could only be achieved with a follow up
program and subsequent intervention when needed.
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Factors Affecting Outcome After Endovascular Repair
(EVPAR) of Popliteal Artery Aneurysms (PAAs)
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Objectives: To analyze factors affecting outcome after
EVPAR.
Methods: Clinical data of consecutive PAA patients
treated with EVPAR (2000-2012) were reviewed. Primary
endpoints were major adverse events: mortality, throm-
bosis, amputation, complications, reinterventions.
Fig. Primary patency.
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Volume 57, Number 5S Abstracts 69SResults: EVPAR was performed in 46 limbs, 38
patients, elective: 33 (72%), emergent: 13 (28%). One
aneurysm ruptured, 12 caused acute ischemia (12 under-
went thrombolysis+ EVPAR). Mean of 2.0 Viabahn
stent-grafts (range, 1-4) were used. Sixteen procedures
(35%) were performed percutaneously, 30 through femoral
cutdown. Technical success was 98%. Thirty-day mortality
was 4.4%, all after emergencies (15.4%, 2/13). Thirty-day
primary and secondary patencies were 100% for elective,
75% and 84%, respectively for emergencies. Two major
amputations (15.4%) were done after emergent EVPAR.
Early complications were more frequent after emergencies
(77% vs 12%; P < .0001). Intracranial hemorrhage
occurred in one patient (2.2%). Mean follow-up was 2.2
years (30 days-8.6 years). At 2 years, primary patencies
were 70% and 64% (P ¼ .44), secondary patencies 80%
and 84%, (P ¼ .79); no limb was lost in elective cases,
limb salvage was 84% for emergencies (P ¼ .02); reinter-
ventions were similar (19% and 30%); major adverse events
occurred after 20 procedures (44%) (elective, 38%; emer-
gent, 64%; P ¼ .01). There were 5 conversions (elective,
4; emergent, 1). Factors affecting adverse events included
emergent EVPAR and percutaneous placement.
Conclusions: PAA with acute presentation continues
to have elevated mortality (16%) and limb loss (16%).
Although elective EVPAR has excellent early results, 2-
year patency of 80% remains a concern.
Author Disclosures: T. C. Bower: Nothing to disclose;
A. A. Duncan: Nothing to disclose; M. D. Fleming:
Nothing to disclose; P. Gloviczki: Nothing to disclose;
Y. Huang: Nothing to disclose; M. Kalra: Nothing to
disclose; G. S. Oderich: Gore,Consulting fees or other
remuneration (payment)Cook,Consulting fees or other
remuneration (payment)PS134.
Clinical Outcome Following Endovascular Therapy for
Femoropopliteal Lesion With TASCII Class A and B
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Objectives: The aim of this study was to investigate
the outcome following endovascular therapy(EVT) for
femoropopliteal(FP) lesion classiﬁed into TransAtlantic
Inter-Society Consensus (TASC) II class A and B.
Methods: This study was a multicenter retrospective
analysis. A total of 2742 consecutive patients (3471limbs)
with FP disease and 2003 limbs with TASCII class A and
B lesions were analyzed in current study; 1169 (58.4%)
were stenting, 834 (41.6%) were plain old balloon angio-
plasty (POBA) alone.
Results: The mean follow-up term were 4.6 6 0.1
years. The mean reference vessel diameter (RVD) was 58.7
6 33.8 mm and the mean lesion length was 5.2 6 1.0
mm. Primary patency was signiﬁcantly higher in the stent
group (85.3%, 69.6% and 59.9% at 1, 3 and 5 years) than
that in the POBA group (76.2%, 59.6% and 49.3% at 1, 3
and 5 years; P < .0001). Assisted primary patency was also
better in the stent group than that in the POBA group
(P ¼ .0002) and the difference in secondary patencybetween in the two groups was similarly signiﬁcant (P ¼
.006). Limited to lesions with RVD below 4.5 mm, there
was no difference in primary patency between in the two
groups (stent vs POBA; 73.0% vs 74.8%, 57.2% vs 53.2%
and 46.8% vs 45.4% at 1, 3 and 5 years; P ¼ .67). Diabetes,
hemodialysis, the history of cerebrovascular disease, absence
of cilostazol, POBA alone andRVD<4.5mmwere found to
be independent predictors of primary patency.
Conclusions: FP stenting improves the primary, assis-
ted-primary and secondary patency for the femoropopliteal
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Predictors of 30-Day Readmission and Postdischarge
Mortality Following Lower Extremity Amputation in
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Objectives: Postoperative readmission is associated
with increased morbidity and mortality. We evaluated risk
factors for readmission and postdischarge adverse events
following lower extremity amputation in the ACS-NSQIP.
Methods: All patients undergoing transmetatarsal
(TMA), below-knee (BKA) or above-knee amputation
(AKA) in the 2011 NSQIP were identiﬁed. Independent
predictors of 30-day readmission were determined using
multivariable logistic regression.
Results: 3438 patients underwent amputation (TMA,
12%; BKA, 50%; AKA, 38%). Readmission rate was 18%.
Thirty-day mortality rate was 8.3% (TMA, 3%; BKA, 6%;
AKA, 13%; P < .01) with 44% of deaths occurring post-
discharge. Overall complication rate was 47% (in-hospital,
41%; postdischarge, 9%). Postdischarge complications
were readmitted in 71% of cases. Amputation level was
not associated with increased complication rate or readmis-
sion rate. Independent predictors of readmission included
OR take-back (OR, 7.0; 95% CI, 5.4-9.0), preoperative
